![AI Pilot Program Proposed to Detect Medicare Fraud](https://www.g2intelligence.com/wp-content/uploads/2024/03/Apr24.LIA_.AI-Pilot-Program.TC-67094-iStock-1482755540-1100x800-1-1080x675.jpg)
AI Pilot Program Proposed to Detect Medicare Fraud
Program outlined in a recently introduced bill would test AI’s effectiveness in detecting suspect payments for diagnostic tests and DME.
Program outlined in a recently introduced bill would test AI’s effectiveness in detecting suspect payments for diagnostic tests and DME.
How clinical laboratory professionals can advocate for legislative and regulatory improvements
Joyce Gresko, partner at Alston & Bird, discusses the latest on PAMA and what will likely need to happen for SALSA to pass in 2024.
Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.
Comments on the FDA’s proposed rule to regulate LDTs as in vitro diagnostic devices reveal mixed reactions.